Reviva Pharmaceuticals (RVPH) Institutional Ownership $0.87 -0.01 (-0.65%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$0.87 +0.01 (+0.70%) As of 05/2/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)CurrentInstitutional OwnershipPercentage63.18%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$904.04KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.06M Get RVPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RVPH Institutional Buying and Selling by Quarter Reviva Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/2/2025 BluePointe Capital Management LLC47,185$45K0.0%+354.7%0.101% 2/17/2025Tang Capital Management LLC170,000$308K0.0%N/A0.508% 2/17/2025Millennium Management LLC1,804,488$3.27M0.0%-1.5%5.396% 2/17/2025Focus Partners Wealth60,000$109K0.0%-62.7%0.179% 2/17/2025Cornerstone Select Advisors LLC17,500$32K0.0%N/A0.052% 2/17/2025Ameriprise Financial Inc.46,467$84K0.0%N/A0.139% 2/14/2025Schonfeld Strategic Advisors LLC1,058,100$1.92M0.0%-30.2%3.164% 2/14/2025Tower Research Capital LLC TRC 26,775$48K0.0%+848.8%0.080% 2/13/2025XTX Topco Ltd25,020$45K0.0%N/A0.075% 2/13/2025Raymond James Financial Inc.14,000$25K0.0%N/A0.042% Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025Geode Capital Management LLC311,701$564K0.0%+11.9%0.932% 2/6/2025Raymond James Financial Inc.14,000$25K0.0%N/A0.042% 1/23/2025EMC Capital Management44,535$81K0.0%+142.0%0.133% 1/22/2025Drive Wealth Management LLC20,000$36K0.0%N/A0.060% 11/16/2024Geode Capital Management LLC278,496$401K0.0%+17.9%0.833% 5/10/2024Vanguard Group Inc.1,001,836$3.79M0.0%+2.8%3.588% 2/13/2024Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318% 1/30/2024 Vontobel Holding Ltd.14,000$72K0.0%N/A0.062% 11/15/2023Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649% 11/9/2023EMC Capital Management123,915$613K0.4%+1,294.3%0.547% 8/7/2023Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071% 7/27/2023Virtu Financial LLC18,448$108K0.0%N/A0.090% 2/15/2023Tang Capital Management LLC24,125$103K0.0%N/A0.118% 2/13/2023EMC Capital Management123,915$527K0.5%+125.0%0.606% 2/1/2023Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033% 11/7/2022Virtu Financial LLC46,119$73K0.0%N/A0.226% 10/25/2022Raymond James & Associates33,000$52K0.0%+65.0%0.161% 2/10/2022EMC Capital Management55,078$159K0.1%-27.4%0.364% 2/3/2022Northwestern Mutual Wealth Management Co.9,299$27K0.0%N/A0.067% 11/9/2021BlackRock Inc.33,470$136K0.0%+82.7%0.241% 8/17/2021Armistice Capital LLC714,700$3.47M0.1%N/A7.742% 8/13/2021Renaissance Technologies LLC11,250$55K0.0%N/A0.122% 8/13/2021Northern Trust Corp10,584$51K0.0%N/A0.115% 8/13/2021Geode Capital Management LLC67,724$329K0.0%N/A0.734% 8/13/2021Vanguard Group Inc.529,464$2.57M0.0%N/A5.735% 7/28/2021 DAVENPORT & Co LLC10,000$49K0.0%-33.3%0.108% 5/21/2021Citadel Advisors LLC36,652$210K0.0%N/A0.397% 5/18/2021Millennium Management LLC35,310$203K0.0%N/A0.382% 5/18/2021Citadel Advisors LLC36,652$210K0.0%N/A0.397% 4/28/2021 DAVENPORT & Co LLC15,000$86K0.0%N/A0.162% $2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now.(Data available from 1/1/2016 forward) RVPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RVPH shares? During the previous two years, 18 institutional investors and hedge funds held shares of Reviva Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($9.09M), Vanguard Group Inc. ($3.79M), Millennium Management LLC ($3.27M), Schonfeld Strategic Advisors LLC ($1.92M), Geode Capital Management LLC ($564K), Tang Capital Management LLC ($308K), and Focus Partners Wealth ($109K).Learn more on RVPH's institutional investors. What percentage of Reviva Pharmaceuticals stock is owned by institutional investors? 63.18% of Reviva Pharmaceuticals stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings. Which institutional investors have been buying Reviva Pharmaceuticals stock? Of the 15 institutional investors that purchased Reviva Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.16M), Tang Capital Management LLC ($170K), EMC Capital Management ($141.16K), Geode Capital Management LLC ($75.58K), Ameriprise Financial Inc. ($46.47K), BluePointe Capital Management LLC ($36.81K), and Raymond James Financial Inc. ($28K). How much institutional buying is happening at Reviva Pharmaceuticals? Institutional investors have bought a total of 1,816,189 shares in the last 24 months. This purchase volume represents approximately $7.69M in transactions. Which Reviva Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Schonfeld Strategic Advisors LLC ($457.80K), Armistice Capital LLC ($224K), Focus Partners Wealth ($101K), and Millennium Management LLC ($28.33K). How much institutional selling is happening at Reviva Pharmaceuticals? Institutional investors have sold a total of 811,126 shares in the last 24 months. This volume of shares sold represents approximately $2.16M in transactions. Related Companies PRQR Major Shareholders TNGX Major Shareholders FDMT Major Shareholders TLSA Major Shareholders LFVN Major Shareholders LRMR Major Shareholders NBTX Major Shareholders PBYI Major Shareholders CYBN Major Shareholders ACRS Major Shareholders This page (NASDAQ:RVPH) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RVPH Stock Free RVPH Stock Alerts